Clinical Outcomes With Once‐Weekly Insulin Icodec Versus Once‐Daily Insulin Glargine U100 in Insulin‐Naïve and Previously Insulin‐Treated Individuals With Type 2 Diabetes: A Meta‐Analysis of Randomised Controlled Trials

Clinical Outcomes With Once‐Weekly Insulin Icodec Versus Once‐Daily Insulin Glargine U100 in Insulin‐Naïve and Previously Insulin‐Treated Individuals With Type 2 Diabetes: A Meta‐Analysis of Randomised Controlled Trials

ABSTRACT Aims The once‐weekly insulin icodec, a new basal insulin analog, may positively support a reduction in injection frequency and improve adherence to therapy in type 2 diabetes (T2D). This study aimed to evaluate the safety and efficacy of insulin icodec compared with those of once‐daily glar...

Full description

Bibliographic Details
Main Authors: Mushood Ahmed, Aimen Shafiq, Hira Javaid, Hritvik Jain, Abdulqadir J. Nashwan, Qura Tul‐Ain, Jawad Basit
Format: Article
Language:English
Published: Wiley 2024-05-01
Series:Endocrinology, Diabetes & Metabolism
Subjects:
insulin
insulin glargine
insulin icodec
type 2 diabetes
Online Access:https://doi.org/10.1002/edm2.480

Internet

https://doi.org/10.1002/edm2.480

Similar Items